InvestorsHub Logo
Followers 58
Posts 10050
Boards Moderated 1
Alias Born 09/21/2016

Re: drv17 post# 207551

Wednesday, 08/28/2019 9:54:39 AM

Wednesday, August 28, 2019 9:54:39 AM

Post# of 458743
drv17

In a quick glance through Anavex 2-73 was the only sigma 1 receptor mentioned that I saw.

Thank you for posting this Pineapple and Nidan

Excerpted from "frontiers in Nuroscience" article -
Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
Role of S1R in Alzheimer’s Disease (AD)



Thank you drv17. I looked but did not see any contradictions to anything previously claimed by AVXL. It has been my mission to search for contradictions and in fact I see numerous repeated ref here which look like the same claim from Anavex in previous pubs. Admit I am probably not qualified to do a definitive search.

As we know AVXL chose not to go the IPO route. IMO, that may mean there are many WS who stand to be on the outside(instead of in the drivers seat) if the claims made by AVXL are validated. They will miss out on massive cash flow. Dr.M. must be despised in that crowd. The last thing WS wants to see is blah, blah. Anyways, lets hope Dr.M. has a food taster and car starter on staff.

So, we just do not know what has been going on w/the pub errors and this example today of a big pub which seems to at least agree in theory w/previous AVXL claims on CNS Homeostasis.

There is an old expression that comes to mind. "You are not paranoid, they really are after you."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News